Aminoglycosides in critically ill patients: which dosing regimens for which pathogens?
Amélie Marsot, Sami Hraiech, Nadim Cassir, Florence Daviet, Gabriel Parzy, Olivier Blin, Laurent Papazian, Romain Guilhaumou
Topics & Concepts
MedicineTobramycinAminoglycosideAmikacinPopulationVolume of distributionDosingPharmacokineticsRenal functionInternal medicineAntibacterial agentGentamicinUrologyAntibioticsMicrobiologyBiologyEnvironmental healthAntibiotics Pharmacokinetics and EfficacyPneumonia and Respiratory InfectionsAntibiotic Resistance in Bacteria